Projects IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities. Breadcrumb Home Keywords Research group - Any -Cell Virology and Immunology (VIC)HIV and HVC Genetic and Phenotypic VariabilityImmunology (IGG)Microbial Genomics (GEM)Neoantigens and Vaccines against Cancer (NeoVaCan)Pathogen Immunity, Signalling and Therapeutic Applications (PISTA)Retrovirology and Clinical Studies (GREC)T-cell Immunology and Vaccines (TIV)Tissue Virology (VITI)Translational Research in Immunology and Ageing (TRIA)Viral Immune Evasion and Vaccines (VIRIEVAC)Virus-Host Interactions (ViHIT) Researcher - Any -Aleix Elizalde TorrentAlejandro Riquelme GrauAlessandra BorgognoneAlex Olvera van der StoepAmaya Blanco PereraAnaí Villanueva DelgadoAnna López PlanaAnna Pons GrifolsArnau Creus OrodeaBeatriz Mothe PujadasBenjamin TrinitéBonaventura Clotet SalaCarla Rovirosa MartíCarlos Ávila NietoCarmen Aguilar GurrieriCecilia Cabrera NavarroChristian BranderCristina GálvezCristina Mesa RealCristina Peligero CruzCristina Ramírez SotoDàlia Raïch ReguéEdurne García VidalEdwards Pradenas SaavedraElena Lapaz LorenzoElisabet Fernández RosasElisabet García RodríguezElisabet Pallarés Elisa Molina MolinaEloi Franco Trepat Erola Ainsua EnrichEster Ballana GuixEudald Felip FalgàsEudald Vehí PiquéEulalia Grau SegúEva Armendariz BurgoaEva Riveira MuñozFernando Laguía NuedaFerran Abancó i EspugaFrancesc Català MollFrancesc Cunyat ViaplanaFrancisco M. Muñoz LópezGabriel Felipe Rodríguez LozanoGerard Campos GonzalezGooya BanaeiGustavo Rodríguez EstebanIgnasi Calba IñiguezIgor Moraes CardosoIrene González NavarroItziar Erkizia JauregiJakub ChojnackiJavier Martínez-PicadoJoan Pagès OliverasJon Izquierdo PujolJordi Senserrich VelascoJorge Carrillo MolinaJosé Luis Pérez GuillamónJudith Dalmau MorenoJulia García PradoJulià Blanco ArbuésJulián Eslava CampoJúlia Albó DelgadoLaia Bernad RosaLaia Vives AdriánLaura Planells FerrerLidia Garrido SanzLidia Ruiz TabuencaLluís Revilla SanchoLourdes Grau ParéLucía Gómez EspadaMacedonia Trigueros PeñaManel Garcia de la FuenteMarc Noguera i JulianMaria Casadellà FontdevilaMaria Nevot BanúsMaria Salgado BernalMarina Martinez VelascoMarina Matilla MartínezMarina Pino CebriánMariona Parera SallentMarissa Flores SantamaríaMarta Massanella LunaMarta Ruiz RiolMaría Lázaro DíezMiguel Ángel Martínez de la SierraMireia Martínez GameroMª Carmen García GuerreroMª Carmen Puertas CastroMª Luisa Rodríguez de la ConcepciónNatàlia Marrugat VilaNel Marín SánchezNuria Izquierdo UserosNúria de la Iglesia ZaragozaNúria Pedreño LópezOriol Careta BorràsPatricia Piñol JuradoPatricia Resa InfantePenélope Riquelme NevadoRafaela Ayen AparicioRaúl Pérez CaballeroRita Casas CostaRoger Badia CórcolesRoger ParedesRosina Malagrida EscalasRuth Peña PoderósRytis BoreikaSamandhy Cedeño BriceñoSandra Franco CireraSara Cabrero de las HerasSara Morón LópezSilvia Marfil VerchiliSonia Bange SinghSonia Villanueva HernándezSusana Esteban RayaSílvia Ribó GenéTeresa Puig OlivaTetyana PidkovaThuong NguyenTuixent Escribà BelValentina Triviño VenceVíctor Urrea GalesÁngel Bayón Gil From date To date Tumor-specific neoantigens as targets for personalized vaccines Project status Ongoing Start/End 2022 / 2024 Principal investigator Núria de la Iglesia Zaragoza Participating entities IrsiCaixa, ICO, Hospital Germans Trias i Pujol, CNAG-CRG Strategic lines Cancer Financing entity Instituto de Salud Carlos III IrsiCaixa collaborative researchers: Gustavo Rodríguez Esteban, Anna López Plana External collaborative researchers: Rafael Villanueva, Laura Layos, Holger Heyn Role of NK cells in post COVID-19 condition (LoNK-COVID) Project status Ongoing Start/End 2022 / 2025 Principal investigator Maria Nevot Banús Strategic lines Immunopathology Financing entity Ministerio de Ciencia e Innovación (PID2021-124226OB-I00) Boosted Flow Cytometry as a Diagnostic and Monitoring Tool for Virus/Pathogen specific T-Cell immune Profiles in HIV, TB and COVID Diseases Project status Ongoing Start/End 2022 / 2024 Principal investigator Marta Ruiz Riol Strategic lines Cancer Emerging infectious diseases Global infectious diseases Financing entity “la Caixa” Banking Foundation Code: CI21-00100 New antiviral and immunomodulatory therapies against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity Spanish Ministry of Science and Innovation Immune strategies against HIV persistence Project status Ongoing Start/End Principal investigator Bonaventura Clotet Sala Financing entity Ministerio de Ciencia Innovación y Universidades. Instituto de Salud Carlos III RBD Dimer recombinant protein vaccine against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Ruiz Riol Julià Blanco Arbués Christian Brander Jorge Carrillo Molina Samandhy Cedeño Briceño Julia García Prado Nuria Izquierdo Useros Tuixent Escribà Bel Eulalia Grau Segú Beatriz Mothe Pujadas Strategic lines Cancer Emerging infectious diseases Financing entity European Commission Codi: 101046118 Assessment of the antiviral activity against SARS-CoV-2 of certain mouthwashes Project status Ongoing Start/End 2021 / 2022 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity DENTAID S.L. Engineered enveloped VLP’s with high-density antigen coating. A proof of concept for their application in animal health. FeLV vaccines Project status Ongoing Start/End 2021 / 2022 Principal investigator Julià Blanco Arbués Strategic lines Cancer Emerging infectious diseases Financing entity HIPRA Scientific Identification and Validation of Early Biomarkers of Acute COVID-19 to Predict Evolution. IVETTE Project status Ongoing Start/End 2021 / 2024 Principal investigator Bonaventura Clotet Sala Julià Blanco Arbués Financing entity Fundació "la Marató de TV3" Code: 202113-31 Immunity against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2023 Principal investigator Julià Blanco Arbués Strategic lines Cancer Emerging infectious diseases Financing entity #YoMeCorono crowdfunding campaign Pagination 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next Last
Tumor-specific neoantigens as targets for personalized vaccines Project status Ongoing Start/End 2022 / 2024 Principal investigator Núria de la Iglesia Zaragoza Participating entities IrsiCaixa, ICO, Hospital Germans Trias i Pujol, CNAG-CRG Strategic lines Cancer Financing entity Instituto de Salud Carlos III IrsiCaixa collaborative researchers: Gustavo Rodríguez Esteban, Anna López Plana External collaborative researchers: Rafael Villanueva, Laura Layos, Holger Heyn
Role of NK cells in post COVID-19 condition (LoNK-COVID) Project status Ongoing Start/End 2022 / 2025 Principal investigator Maria Nevot Banús Strategic lines Immunopathology Financing entity Ministerio de Ciencia e Innovación (PID2021-124226OB-I00)
Boosted Flow Cytometry as a Diagnostic and Monitoring Tool for Virus/Pathogen specific T-Cell immune Profiles in HIV, TB and COVID Diseases Project status Ongoing Start/End 2022 / 2024 Principal investigator Marta Ruiz Riol Strategic lines Cancer Emerging infectious diseases Global infectious diseases Financing entity “la Caixa” Banking Foundation Code: CI21-00100
New antiviral and immunomodulatory therapies against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity Spanish Ministry of Science and Innovation
Immune strategies against HIV persistence Project status Ongoing Start/End Principal investigator Bonaventura Clotet Sala Financing entity Ministerio de Ciencia Innovación y Universidades. Instituto de Salud Carlos III
RBD Dimer recombinant protein vaccine against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Ruiz Riol Julià Blanco Arbués Christian Brander Jorge Carrillo Molina Samandhy Cedeño Briceño Julia García Prado Nuria Izquierdo Useros Tuixent Escribà Bel Eulalia Grau Segú Beatriz Mothe Pujadas Strategic lines Cancer Emerging infectious diseases Financing entity European Commission Codi: 101046118
Assessment of the antiviral activity against SARS-CoV-2 of certain mouthwashes Project status Ongoing Start/End 2021 / 2022 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity DENTAID S.L.
Engineered enveloped VLP’s with high-density antigen coating. A proof of concept for their application in animal health. FeLV vaccines Project status Ongoing Start/End 2021 / 2022 Principal investigator Julià Blanco Arbués Strategic lines Cancer Emerging infectious diseases Financing entity HIPRA Scientific
Identification and Validation of Early Biomarkers of Acute COVID-19 to Predict Evolution. IVETTE Project status Ongoing Start/End 2021 / 2024 Principal investigator Bonaventura Clotet Sala Julià Blanco Arbués Financing entity Fundació "la Marató de TV3" Code: 202113-31
Immunity against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2023 Principal investigator Julià Blanco Arbués Strategic lines Cancer Emerging infectious diseases Financing entity #YoMeCorono crowdfunding campaign